News

New Scripps Research method may help.

Scripps Research is Science Changing Life

The new test could give public health officials and doctors critical information for tracking river blindness outbreaks and treating current infections.

"I'm surprised and honored to be listed among the distinguished awardees," says Shenvi.

Yates’s research in mass spectrometry has been fundamental in establishing the field of large-scale proteomics, a discipline that has shed light on diseases such as malaria and anthrax.

With new funding, researchers aim to control pain without the risk of addiction.

Scientists at Scripps Research have solved the structure of a key protein that senses when our cells swell.

Neuroscientist Candice Contet and colleagues to take a close look how an understudied brain region promotes alcohol drinking.

"This opens up new options for treating diseases of the blood."

An unexpected discovery in two disease-linked proteins could shed light on human immune system disorders, including a rare and often fatal childhood disease.

This landmark study is the first-ever side-by-side comparison of 171 antibodies against Ebola virus.

Scripps Research scientists have developed a powerful new strategy for synthesizing molecular skeletons of chemicals used in drugs and other important products

Scientists have discovered that a microscopic roundworm develops similar nerve damage to human patients when their muscle cells are genetically engineered to produce TTR proteins.

"We can now watch antibody responses evolve almost in real time."

New method for precisely controlling 3D architecture of critical linkages used in potential therapeutics.

"This could give us a way to kill tumors without harming normal cells..."

New Scripps Research study offers guidance for more effective Ebola vaccines.

The $75,000 in award funding will support Engle’s work to invent new tools to make new drug candidates quickly, efficiently and sustainably.

"We’re very pleased to have these stellar scientists join our faculty."

"Our study shows an almost threefold improvement in the rate of diagnosis of AFib in the those actively monitored compared to usual care."

There's new evidence that cardiovascular risk factors can be accurately measured and tracked independently outside of a physician’s office using new mobile health technologies.

The researchers estimated that a single human dose of the drugs would convey an insecticide effect against mosquitos and sand flies lasting 50–90 days.

The research offers another approach for tackling diseases that have been considered “undruggable,” including ALS, muscular dystrophy, cystic fibrosis and certain cancers.

"Dr. Sharpless has made numerous contributions to chemistry that have each significantly moved the field forward."